Diagnosis and staging of pancreatic cancer by endoscopic ultrasound. 1998

K Akahoshi, and Y Chijiiwa, and I Nakano, and H Nawata, and Y Ogawa, and M Tanaka, and E Nagai, and M Tsuneyoshi
Department of Internal Medicine III, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

The aim of this study was to evaluate the usefulness of and problems associated with endoscopic ultrasonography (EUS) in the diagnosis and pre-operative staging of pancreatic cancer. 96 patients suspected of having pancreatic cancer were pre-operatively examined with EUS. 37 of these 96 patients had pancreatic cancer. Results of the EUS imaging were compared with findings of histology and/or surgery, and the patient's clinical course. The sensitivity and specificity of EUS for diagnosing pancreatic cancer were 89% and 97%, respectively. EUS had excellent sensitivity regardless of tumour size or location. EUS was accurate (90%) in determining tumour size in pancreatic cancers less than 3 cm in maximum diameter, but not for tumours greater than 3 cm (30%). The accuracy of tumour (T) and nodal (N) staging were 64% and 50%, respectively. EUS is a promising method for the early diagnosis and pre-operative staging of pancreatic cancers, but requires further refinement.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K Akahoshi, and Y Chijiiwa, and I Nakano, and H Nawata, and Y Ogawa, and M Tanaka, and E Nagai, and M Tsuneyoshi
January 2015, GE Portuguese journal of gastroenterology,
K Akahoshi, and Y Chijiiwa, and I Nakano, and H Nawata, and Y Ogawa, and M Tanaka, and E Nagai, and M Tsuneyoshi
January 2002, Oncology (Williston Park, N.Y.),
K Akahoshi, and Y Chijiiwa, and I Nakano, and H Nawata, and Y Ogawa, and M Tanaka, and E Nagai, and M Tsuneyoshi
September 2009, Revista espanola de enfermedades digestivas,
K Akahoshi, and Y Chijiiwa, and I Nakano, and H Nawata, and Y Ogawa, and M Tanaka, and E Nagai, and M Tsuneyoshi
April 2010, European review for medical and pharmacological sciences,
K Akahoshi, and Y Chijiiwa, and I Nakano, and H Nawata, and Y Ogawa, and M Tanaka, and E Nagai, and M Tsuneyoshi
April 2000, Frontiers in bioscience : a journal and virtual library,
K Akahoshi, and Y Chijiiwa, and I Nakano, and H Nawata, and Y Ogawa, and M Tanaka, and E Nagai, and M Tsuneyoshi
January 2009, Journal of clinical ultrasound : JCU,
K Akahoshi, and Y Chijiiwa, and I Nakano, and H Nawata, and Y Ogawa, and M Tanaka, and E Nagai, and M Tsuneyoshi
July 1999, The American surgeon,
K Akahoshi, and Y Chijiiwa, and I Nakano, and H Nawata, and Y Ogawa, and M Tanaka, and E Nagai, and M Tsuneyoshi
April 2010, Surgical oncology clinics of North America,
K Akahoshi, and Y Chijiiwa, and I Nakano, and H Nawata, and Y Ogawa, and M Tanaka, and E Nagai, and M Tsuneyoshi
March 1995, Digestive diseases and sciences,
K Akahoshi, and Y Chijiiwa, and I Nakano, and H Nawata, and Y Ogawa, and M Tanaka, and E Nagai, and M Tsuneyoshi
July 2025, World journal of gastrointestinal oncology,
Copied contents to your clipboard!